Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Overweight 1Obesity 1Breast Neoplasms 1

Interventions

Metformin 7Exenatide 4Vitamin D 2Sugars 2Resistance Training 2penclomedine 1licogliflozin 1exemestane 1dapagliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Weight Reduction Programs 1Therapeutics 1Testosterone 1Taxes 1Tamoxifen 1TOPS 1Surveys and Questionnaires 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Progesterone 1Paclitaxel 1Observation 1Nutrition Assessment 1Naltrexone 1Methods 1Letrozole 1Jogging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Obesity × bupropion hydrochloride, naltrexone hydrochoride drug combination × Clear all
NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡